A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Exelixis
Merck Sharp & Dohme LLC
RayzeBio, Inc.
RayzeBio, Inc.
Aadi Bioscience, Inc.
Sumitomo Pharma America, Inc.
Pfizer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Ipsen
Vanquish Oncology, Inc.
Pfizer
Mauna Kea Technologies
Mauna Kea Technologies
Novartis
Novartis